SPX4,080.11+122.48 3.09%
DIA346.15+7.67 2.27%
IXIC11,468.00+484.22 4.41%

Medtronic Launches Insulin Pump Infusion Sets With Double Wear Time

Benzinga · 11/15/2022 11:03
  • Medtronic plc (NYSE:MDT) has launched the Medtronic Extended infusion set in the U.S., the first and only infusion set labeled for up to 7-day wear
  • An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
  • The Medtronic Extended infusion set uses advanced materials that help reduce insulin preservative loss and maintain insulin flow and stability to double the wear time of an infusion set. 
  • Also read: Medtronic Shares Fall As Blood Pressure Reduction Device Fails On Primary Goal.
  • In clinical studies, study participants observed a decrease in the number of times an infusion set needed to be changed by 50%. The number of infusion set failures associated with high glucose levels was lowered.
  • Additionally, the Medtronic Extended infusion set is estimated to result in annual cost savings of insulin of up to 25% due to a reduced number of the infusion set and reservoir changes that result in unrecoverable insulin as plastic waste reduction of up to 50%.
  • With the U.S. launch of the Medtronic Extended infusion set, this innovation is now available exclusively for customers using MiniMed 600 and 700 series pumps.
  • Price Action: MDT shares are up 0.60% at $83.40 on the last check Tuesday.